1. 1256. Clinical Response by Minimum Inhibitory Concentrations in Carbapenem-Resistant Pseudomonas aeruginosa Infections under Cefiderocol Compassionate Use Program. (4th December 2021) Authors: Satlin, Michael J; Fam, David; Echols, Roger; Longshaw, Christopher; Takemura, Miki; Yamano, Yoshinori Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S717 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1256. Clinical Response by Minimum Inhibitory Concentrations in Carbapenem-Resistant Pseudomonas aeruginosa Infections under Cefiderocol Compassionate Use Program. (4th December 2021) Authors: Satlin, Michael J; Fam, David; Echols, Roger; Longshaw, Christopher; Takemura, Miki; Yamano, Yoshinori Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S717 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1269. Differences in Interpretative Breakpoints Between CLSI, FDA and EUCAST Impact Reporting of Susceptibility and Resistance to Cefiderocol. (31st December 2020) Authors: Yamano, Yoshinori; Takemura, Miki; Longshaw, Christopher; Echols, Roger Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1287. Double Disk Diffusion Study to Evaluate the Synergistic Effect Between Cefiderocol and Ceftazidime-Avibactam Against Cefiderocol-Non-susceptible Acinetobacter baumannii. (4th December 2021) Authors: Yamano, Yoshinori; Takemura, Miki; Anan, Naomi; Echols, Roger; Longshaw, Christopher Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1578. Treatments for complicated urinary tract infections (cUTI) caused by multidrug resistant (MDR) Gram-negative (GN) pathogens- a systematic review and network meta-analysis (NMA). (31st December 2020) Authors: Reason, Tim; Gill, Karan; Longshaw, Christopher; McCool, Rachael; Wilson, Katy; Lopes, Sara Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S787 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 1982. Multiplex PCR-Based Analysis of Enteric Pathogens in Faecal Samples from Patients with Clostridium difficile Infection in the Randomized, Controlled EXTEND Study Comparing the Efficacy of Extended-Pulsed Fidaxomicin With Vancomycin Therapy. (26th November 2018) Authors: Wilcox, Mark; Cornely, Oliver A; Guery, Benoit; Longshaw, Christopher; Georgopali, Areti; Karas, Andreas; Kazeem, Gbenga; Palacios-Fabrega, Jose Alejandro; Vehreschild, Maria J G T Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting. (28th June 2021) Authors: Sadouki, Zahra; McHugh, Timothy D.; Aarnoutse, Rob; Ortiz Canseco, Julio; Darlow, Christopher; Hope, William; van Ingen, Jakko; Longshaw, Christopher; Manissero, Davide; Mead, Andrew; Pelligand, Ludovic; Phee, Lynette; Readman, John; Ruth, Mike M.; Standing, Joseph F.; Stone, Neil; Wey, Emmanuel ... Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 9(2021) Page Start: 2252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Are resistance rates among bloodstream isolates a good proxy for other infections? Analysis from the BSAC Resistance Surveillance Programme. (5th April 2021) Authors: Horner, Carolyne; Mushtaq, Shazad; Allen, Michael; Longshaw, Christopher; Reynolds, Rosy; Livermore, David M Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 7(2021) Page Start: 1822 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing. (15th March 2022) Authors: Matuschek, Erika; Longshaw, Christopher; Takemura, Miki; Yamano, Yoshinori; Kahlmeter, Gunnar Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 6(2022) Page Start: 1662 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Erratum to: In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in France. Issue 3 (24th July 2021) Authors: Naas, Thierry; Lina, Gerard; Henriksen, Anne Santerre; Longshaw, Christopher; Jehl, Francois Journal: JAC-antimicrobial resistance Issue: Volume 3:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗